{"id":"https://openalex.org/W4416636899","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6327","title":"Mechanisms of Resistance to Immune Checkpoint Inhibitors in Advanced Lung Cancer: Insights from a Meta-Analysis of Biomarkers and Combination Therapies","display_name":"Mechanisms of Resistance to Immune Checkpoint Inhibitors in Advanced Lung Cancer: Insights from a Meta-Analysis of Biomarkers and Combination Therapies","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416636899","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6327"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa6327","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6327","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa6327","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pathology and functional genomics","raw_type":"proceedings-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017935492","display_name":"Hassan Tariq","orcid":"https://orcid.org/0000-0002-9822-9756","observed_orcids":["https://orcid.org/0000-0002-9822-9756","https://orcid.org/0009-0002-4017-4972"]},"institutions":[{"id":"https://openalex.org/I224549313","display_name":"Punjab Medical College","ror":"https://ror.org/04hbpw172","country_code":"PK","type":"education","lineage":["https://openalex.org/I224549313"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Hassan Tariq","raw_affiliation_strings":["1Punjab Medical College, Faisalabad, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Punjab Medical College, Faisalabad, Pakistan","institution_ids":["https://openalex.org/I224549313"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113608704","display_name":"Daanyal Siddiqui","orcid":"https://orcid.org/0009-0000-4400-1070","observed_orcids":["https://orcid.org/0009-0000-4400-1070"]},"institutions":[{"id":"https://openalex.org/I224549313","display_name":"Punjab Medical College","ror":"https://ror.org/04hbpw172","country_code":"PK","type":"education","lineage":["https://openalex.org/I224549313"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Daanyal Siddiqui","raw_affiliation_strings":["1Punjab Medical College, Faisalabad, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Punjab Medical College, Faisalabad, Pakistan","institution_ids":["https://openalex.org/I224549313"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010473913","display_name":"Abdullah Khan","orcid":"https://orcid.org/0000-0003-2166-2583","observed_orcids":["https://orcid.org/0000-0003-2166-2583"]},"institutions":[{"id":"https://openalex.org/I224549313","display_name":"Punjab Medical College","ror":"https://ror.org/04hbpw172","country_code":"PK","type":"education","lineage":["https://openalex.org/I224549313"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Abdullah Khan","raw_affiliation_strings":["1Punjab Medical College, Faisalabad, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Punjab Medical College, Faisalabad, Pakistan","institution_ids":["https://openalex.org/I224549313"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I224549313"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA6327","last_page":"PA6327"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/immune-resistance-mechanisms","display_name":"immune resistance mechanisms","score":0.5260000228881836},{"id":"https://openalex.org/keywords/advanced-lung-cancer","display_name":"advanced lung cancer","score":0.8939999938011169},{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.996999979019165},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.996999979019165},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8009999990463257},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9779999852180481},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7080000042915344},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5490000247955322},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8044999837875366},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7071999907493591},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6516000032424927},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5777999758720398},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5580999851226807},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.517300009727478},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5052000284194946},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43050000071525574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40549999475479126},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.3952000141143799},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3384999930858612},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3269999921321869},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.31200000643730164},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.3059999942779541},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.29330000281333923},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.289000004529953},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2806999981403351},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.27390000224113464},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.27149999141693115},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.26649999618530273},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.26499998569488525},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.259799987077713},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.2590000033378601}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa6327","doi":"https://doi.org/10.1183/13993003.congress-2025.pa6327","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa6327","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pathology and functional genomics","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3100650313","https://openalex.org/W7202092124","https://openalex.org/W3024991160","https://openalex.org/W4318197064","https://openalex.org/W4387150569","https://openalex.org/W3087869315","https://openalex.org/W4205155893","https://openalex.org/W7161628404","https://openalex.org/W2977860844","https://openalex.org/W2609355966"],"abstract_inverted_index":{"Background:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"(ICIs)":[4],"have":[5],"improved":[6,106,153],"outcomes":[7],"in":[8,109,134,148,166],"advanced":[9,58],"lung":[10,59,202],"cancer,":[11],"but":[12],"up":[13],"to":[14,122,146],"40%":[15],"of":[16,48,111,136],"patients":[17,61],"experience":[18],"primary":[19],"or":[20],"acquired":[21],"resistance,":[22],"driven":[23],"by":[24,156],"diverse":[25,76],"molecular":[26],"and":[27,35,52,73,90,116,158,182,191],"immunological":[28],"mechanisms.":[29],"Objectives:":[30],"To":[31],"identify":[32],"resistance":[33,181],"mechanisms":[34],"guide":[36,195],"next-generation":[37],"combination":[38,196],"therapies":[39],"for":[40,198],"durable":[41,173,199],"remission.":[42],"Methods:":[43],"We":[44],"conducted":[45],"a":[46],"meta-analysis":[47],"38":[49],"clinical":[50],"trials":[51,137],"registries":[53,68],"(2015\u20132024),":[54],"analyzing":[55],"over":[56],"25,000":[57],"cancer":[60,203],"treated":[62],"with":[63,105],"PD-1/PD-L1":[64],"inhibitors.":[65],"Data":[66],"from":[67,120],"across":[69],"North":[70],"America,":[71],"Europe,":[72],"Asia":[74],"ensured":[75],"representation.":[77],"Multivariate":[78],"regression":[79],"analyzed":[80],"biomarkers,":[81],"including":[82],"tumor":[83],"mutational":[84],"burden":[85],"(TMB),":[86],"regulatory":[87,129],"T-cell":[88,130],"infiltration,":[89],"cytokine":[91,192],"dysregulation.":[92],"Statistical":[93],"significance":[94],"was":[95],"set":[96],"at":[97],"p<0.05.":[98],"Results:":[99],"High":[100],"TMB":[101],"(>10":[102],"mutations/Mb)":[103],"correlated":[104],"response":[107],"rates":[108],"65%":[110],"cohorts":[112],"(OR":[113],"2.3,":[114],"p<0.001)":[115],"extended":[117],"median":[118],"survival":[119,155],"9.7":[121],"15.2":[123],"months":[124],"(HR":[125,138],"0.68,":[126],"p<0.001).":[127],"Elevated":[128],"infiltration":[131],"predicted":[132,172],"progression":[133],"34%":[135],"1.45,":[139],"p<0.001),":[140],"while":[141],"low":[142],"PD-L1":[143],"(<1%)":[144],"linked":[145],"relapse":[147],"75%.":[149],"VEGF/EGFR":[150],"inhibitor":[151],"combinations":[152],"progression-free":[154],"39%,":[157],"dual":[159],"CTLA-4":[160],"blockade":[161],"achieved":[162],"24%":[163],"complete":[164],"responses":[165],"TMB-high":[167],"groups.":[168],"Baseline":[169],"IFN-\u03b3":[170],"elevations":[171],"remission":[174],"(p=0.002).":[175],"These":[176],"findings":[177],"reveal":[178],"multifactorial":[179],"ICI":[180],"emphasize":[183],"biomarker-driven":[184],"strategies.":[185],"Conclusion:":[186],"Biomarkers":[187],"like":[188],"TMB,":[189],"PD-L1,":[190],"dysregulation":[193],"should":[194],"strategies":[197],"responses,":[200],"advancing":[201],"immunotherapy":[204],"globally.":[205]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2025-11-25T00:00:00"}